The best strategy to control the risk of diabetes in prediabetes is lifestyle management followed by pharmacological interventions
de van der Schueren MAE, Laviano A, Blanchard H, Jourdan M, Arends J, Baracos VE
Pfizers danuglipron and other oral peptides aim to combine the clinical benefits of GLP-1 with the convenience of oral administration - potentially increasing patient adherence and uptake
MEDI0382, a GLP/glucagon receptor dual agonist, significantly reduces hepatic fat content in subjects with type 2 diabetes mellitus
[DOI] [PMC free article] [PubMed] [Google Scholar] 50.Stein LM, McGrath LE, Lhamo R, Koch-Laskowski K, Fortin SM, Skarbaliene J, et al
Lets explore the specific techniques we use to achieve these results